HTRA2 and neoplasm: MUC4 can promote tumor growth by suppressing apoptosis and may be a valuable prognostic marker and therapeutic target.86, 87, 88 Higher mRNA expression of HTRA2 is associated with higher clinicopathological stage and worse prognosis in gastric cancer.89